# Telehealth is widely used by older adults insured by Medicare, new research shows

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/telehealth-utilization-older-adults-medicare/
> **Published:** 2026-04-25T03:38:00-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:02:24-04:00
> **Clinical Summary:** Explore telehealth utilization older adults insured by Medicare and its impact on cannabis medicine access and care delivery for elderly patients.

---

✦ New

 CED Clinical Relevance
 #5
 Clinical Context
 Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape.

ResearchAgingPolicy

 Clinical Summary

This research examining telehealth utilization among Medicare-insured older adults reveals that digital healthcare delivery has achieved substantial adoption in this population, which has direct implications for [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) clinicians seeking to expand access to geriatric patients. As older adults increasingly use telehealth for routine medical consultations, cannabis prescribers should recognize that this cohort is becoming more comfortable with remote consultations, potentially reducing barriers to cannabis assessment and monitoring in elderly patients who may have mobility limitations or live in underserved areas. The widespread adoption of telehealth infrastructure among Medicare beneficiaries also suggests that regulatory and reimbursement pathways for remote cannabis consultations may become more feasible, particularly as state medical boards and payers become more familiar with telehealth workflows. For clinicians managing [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), nausea, or other conditions in older adults where cannabis may be therapeutically relevant, telehealth capacity offers an opportunity to provide more accessible evaluations and follow-up care while addressing the practical challenges this population faces in attending in-person appointments. The growing comfort with remote healthcare in this demographic could also improve medication adherence and safety monitoring, as patients can more easily schedule follow-ups to assess cannabis efficacy and adverse effects. Clinicians should consider integrating telehealth into their cannabis practice models to better serve older, Medicare-insured patients who already demonstrate comfort with this delivery method.

 Dr. Caplan’s Take
 “What we’re seeing with telehealth adoption in Medicare beneficiaries is a direct pathway to improve cannabis medicine access for older patients who have mobility limitations or live in rural areas where there’s no local expertise, and I’m documenting that these patients achieve better outcomes when they can access specialized consultation without the burden of travel.”

 Clinical Perspective

As telehealth adoption accelerates among Medicare beneficiaries, cannabis-related consultations and monitoring may increasingly occur in virtual settings, presenting both opportunities and challenges for clinicians managing older adults with [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/). While telehealth expands access to care for patients in remote areas or with mobility limitations, the inability to conduct physical examination, assess for intoxication, or directly observe functional status during virtual visits may compromise the evaluation of cannabis-related adverse effects such as falls, [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), or drug interactions in this vulnerable population. Clinicians should recognize that older adults may underreport [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) to telehealth providers compared to in-person visits, particularly if they perceive stigma, and should actively screen for cannabis use given the increasing prevalence and variable legal status across states. When managing older patients via telehealth, providers should establish clear protocols for cannabis assessment that include explicit questioning about products and dosing, coordination with pharmacy records, and

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Telehealth%20is%20widely%20used%20by%20older%20adults%20insured%20by%20Medicare%2C%20new%20%3Cb%3Eresearch%3C%2Fb%3E%20shows%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Ftelehealth-is-widely-used-by-older-adults-insured-by-medicare-new-research-shows%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Ftelehealth-is-widely-used-by-older-adults-insured-by-medicare-new-research-shows%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Telehealth%20is%20widely%20used%20by%20older%20adults%20insured%20by%20Medicare%2C%20new%20%3Cb%3Eresearch%3C%2Fb%3E%20shows%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Ftelehealth-is-widely-used-by-older-adults-insured-by-medicare-new-research-shows%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[California Bill to Authorize Medical Cannabis Drive-Thrus Advances to Assembly Floor Vote](https://cedclinic.com/california-bill-to-authorize-medical-cannabis-drive-thrus-advances-to-assembly-floor-vote/)

Learn about the latest legislative efforts in California to improve [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) through drive-thru services.

[Read More](https://cedclinic.com/california-bill-to-authorize-medical-cannabis-drive-thrus-advances-to-assembly-floor-vote/)

[German Advocates: Cannabis Flowers Are Necessary For Medical Care](https://cedclinic.com/german-advocates-cannabis-flowers-are-necessary-for-medical-care/)

Explore the advocacy for cannabis flower use in medical treatment within Germany and its clinical relevance.

[Discover More](https://cedclinic.com/german-advocates-cannabis-flowers-are-necessary-for-medical-care/)

Mellow Fellow: Scientifically Powered Cannabinoids – Cannabis Now

Dive into the science behind cannabinoid formulations and their therapeutic potential in modern cannabis medicine.

Learn More

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
